Astrim Holdings was founded in 2015 as part of a healthcare sector platform build-up investment. The group is controlled by the Metier Capital Growth Fund II Partnership (“Metier”), which has a significant track record of private equity and growth capital transactions.

Astrim’s primary focus is the acquisition of controlling equity stakes in existing profitable businesses that operate in the broader healthcare sector – including Over-The-Counter and Complementary (CAMS) medicines, health foods, personal care products and medical devices.